Back

Acute hospitalised heart failure: SGLT2 inhibitors.

26 August 2022 (14:37 - 14:56)
Organised by:
Congress Presentation Part of: Acute hospitalised heart failure: recent positive trials and their clinical relevance Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Shelley Zieroth

St. Boniface Hospital, University of Manitoba, Winnipeg (Canada)

3 More presentations in this session

Presentation thumbnail
Acute hospitalised heart failure: sacubitril/valsartan.
Professor M. Senni (Bergamo, IT)
Slides Video
Presentation thumbnail
Acute hospitalised heart failure: ferric carboxymaltose.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
Putting it all together: drug treatment of acute hospitalised heart failure.
Doctor M. Costanzo (Naperville, US)
Slides Video

Access the full session

Session thumbnail
Acute hospitalised heart failure: recent positive trials and their clinical relevance
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 14:37 CET
You may be interested in
thumbnail
Congress Presentation
What value do SGLT2 inhibitors offer to patients hospitalised for heart failure?
26 August 2023
thumbnail
Congress Session
Practical guidance to implement heart failure treatment with SGLT2 inhibitors in the outpatient setting
27 August 2023
thumbnail
Congress Presentation
Timing matters: clinical outcomes of early sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure
10 May 2026
thumbnail
Congress Presentation
SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources